Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Genotypic and Phenotypic Characterization of the O-Linked Protein Glycosylation System Reveals High Glycan Diversity in Paired Meningococcal Carriage Isolates.

Børud B, Bårnes GK, Brynildsrud OB, Fritzsønn E, Caugant DA.

J Bacteriol. 2018 Jul 25;200(16). pii: e00794-17. doi: 10.1128/JB.00794-17. Print 2018 Aug 15.

2.

Molecular characterization of clinical and environmental isolates of Legionella pneumophila in Norway, 2001-2008.

Wedege E, Bolstad K, Borgen K, Fritzsønn E, Caugant DA.

Scand J Infect Dis. 2013 Jan;45(1):59-64. doi: 10.3109/00365548.2012.710855. Epub 2012 Sep 19.

PMID:
22992204
3.

Interlaboratory standardization of the sandwich enzyme-linked immunosorbent assay designed for MATS, a rapid, reproducible method for estimating the strain coverage of investigational vaccines.

Plikaytis BD, Stella M, Boccadifuoco G, DeTora LM, Agnusdei M, Santini L, Brunelli B, Orlandi L, Simmini I, Giuliani M, Ledroit M, Hong E, Taha MK, Ellie K, Rajam G, Carlone GM, Claus H, Vogel U, Borrow R, Findlow J, Gilchrist S, Stefanelli P, Fazio C, Carannante A, Oksnes J, Fritzsønn E, Klem AM, Caugant DA, Abad R, Vázquez JA, Rappuoli R, Pizza M, Donnelly JJ, Medini D.

Clin Vaccine Immunol. 2012 Oct;19(10):1609-17. Epub 2012 Aug 8.

4.

Specificity of subcapsular antibody responses in Ethiopian patients following disease caused by serogroup A meningococci.

Norheim G, Aseffa A, Yassin MA, Mengistu G, Kassu A, Fikremariam D, Tamire W, Merid Y, Høiby EA, Caugant DA, Fritzsønn E, Tangen T, Melak B, Berhanu D, Harboe M, Kolberg J, Rosenqvist E.

Clin Vaccine Immunol. 2008 May;15(5):863-71. doi: 10.1128/CVI.00252-07. Epub 2008 Mar 12.

5.

Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7.

Norheim G, Aseffa A, Yassin MA, Mengistu G, Kassu A, Fikremariam D, Tamire W, Merid Y, Høiby EA, Caugant DA, Fritzsønn E, Tangen T, Alebel T, Berhanu D, Harboe M, Rosenqvist E.

Clin Vaccine Immunol. 2007 Apr;14(4):451-63. Epub 2007 Feb 14.

6.

Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.

Norheim G, Aase A, Caugant DA, Høiby EA, Fritzsønn E, Tangen T, Kristiansen P, Heggelund U, Rosenqvist E.

Vaccine. 2005 May 31;23(29):3762-74. Epub 2005 Mar 14.

PMID:
15893613
7.

Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease.

Norheim G, Arne Høiby E, Caugant DA, Namork E, Tangen T, Fritzsønn E, Rosenqvist E.

Vaccine. 2004 Jun 2;22(17-18):2171-80.

PMID:
15149774
8.

Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant.

Bjerre A, Brusletto B, Mollnes TE, Fritzsønn E, Rosenqvist E, Wedege E, Namork E, Kierulf P, Brandtzaeg P.

J Infect Dis. 2002 Jan 15;185(2):220-8. Epub 2002 Jan 3.

PMID:
11807696

Supplemental Content

Loading ...
Support Center